Protein metalation by metal-based drugs: reactions of cytotoxic gold compounds with cytochrome c and lysozyme

[1]  Zhiqiang Liu,et al.  Probing the interaction of cisplatin with cytochrome C by electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry. , 2012, Analytical chemistry.

[2]  J. Helliwell,et al.  Structural studies of the effect that dimethyl sulfoxide (DMSO) has on cisplatin and carboplatin binding to histidine in a protein. , 2012, Acta crystallographica. Section D, Biological crystallography.

[3]  L. Messori,et al.  Protein targets for anticancer gold compounds: mechanistic inferences. , 2011, Anti-cancer agents in medicinal chemistry.

[4]  A. Casini,et al.  Mechanistic studies on two dinuclear organogold(III) compounds showing appreciable antiproliferative properties and a high redox stability. , 2011, Metallomics : integrated biometal science.

[5]  A. Timerbaev,et al.  Recent progress in the application of analytical techniques to anticancer metallodrug proteomics , 2011 .

[6]  S. Ciurli,et al.  Chemistry of Ni2+ in urease: sensing, trafficking, and catalysis. , 2011, Accounts of chemical research.

[7]  C. Fenselau,et al.  Evidence for operation of the direct zinc ligand exchange mechanism for trafficking, transport, and reactivity of zinc in mammalian cells. , 2011, Journal of inorganic biochemistry.

[8]  L. Messori,et al.  Structural and solution chemistry, protein binding and antiproliferative profiles of gold(I)/(III) complexes bearing the saccharinato ligand. , 2011, Journal of inorganic biochemistry.

[9]  A. Casini,et al.  X-ray absorption spectroscopy studies of the adducts formed between cytotoxic gold compounds and two major serum proteins , 2011, JBIC Journal of Biological Inorganic Chemistry.

[10]  S. Wölfl,et al.  Benzimidazol-2-ylidene gold(I) complexes are thioredoxin reductase inhibitors with multiple antitumor properties. , 2010, Journal of medicinal chemistry.

[11]  A. Casini,et al.  [Au2(phen(2Me))2(μ-O)2](PF6)2, a Novel Dinuclear Gold(III) Complex Showing Excellent Antiproliferative Properties. , 2010, ACS medicinal chemistry letters.

[12]  A. Casini,et al.  Gold compounds as anticancer agents: chemistry, cellular pharmacology, and preclinical studies , 2010, Medicinal research reviews.

[13]  Ivano Bertini,et al.  Cellular copper distribution: a mechanistic systems biology approach , 2010, Cellular and Molecular Life Sciences.

[14]  A. Casini,et al.  Anticancer Therapeutics That Target Selenoenzymes: Synthesis, Characterization, in vitro Cytotoxicity, and Thioredoxin Reductase Inhibition of a Series of Gold(I) Complexes Containing Hydrophilic Phosphine Ligands , 2010, ChemMedChem.

[15]  A. Casini,et al.  Chemistry, antiproliferative properties, tumor selectivity, and molecular mechanisms of novel gold(III) compounds for cancer treatment: a systematic study , 2009, JBIC Journal of Biological Inorganic Chemistry.

[16]  A. Casini,et al.  Thioredoxin reductase: A target for gold compounds acting as potential anticancer drugs , 2009 .

[17]  S. Berners‐Price,et al.  Mitochondria-targeted chemotherapeutics: the rational design of gold(I) N-heterocyclic carbene complexes that are selectively toxic to cancer cells and target protein selenols in preference to thiols. , 2008, Journal of the American Chemical Society.

[18]  A. Casini,et al.  Biophysical characterisation of adducts formed between anticancer metallodrugs and selected proteins: new insights from X-ray diffraction and mass spectrometry studies. , 2008, Journal of inorganic biochemistry.

[19]  A. Casini,et al.  Structural characterization, solution studies, and DFT calculations on a series of binuclear gold(III) oxo complexes: relationships to biological properties. , 2008, Inorganic chemistry.

[20]  A. Casini,et al.  Gold(III) compounds as anticancer drugs , 2007 .

[21]  A. Holmgren,et al.  The thioredoxin system in cancer. , 2006, Seminars in cancer biology.

[22]  Di Chen,et al.  A novel anticancer gold(III) dithiocarbamate compound inhibits the activity of a purified 20S proteasome and 26S proteasome in human breast cancer cell cultures and xenografts. , 2006, Cancer research.

[23]  A. Casini,et al.  Structural and solution chemistry, antiproliferative effects, and DNA and protein binding properties of a series of dinuclear gold(III) compounds with bipyridyl ligands. , 2006, Journal of medicinal chemistry.

[24]  P. Nguyen,et al.  Thioredoxin reductase as a novel molecular target for cancer therapy. , 2006, Cancer letters.

[25]  S. Ralph,et al.  A mass spectrometric investigation of the binding of gold antiarthritic agents and the metabolite [Au(CN)2]− to human serum albumin , 2006, JBIC Journal of Biological Inorganic Chemistry.

[26]  Ruili Huang,et al.  Anticancer metal compounds in NCI's tumor-screening database: putative mode of action. , 2005, Biochemical pharmacology.

[27]  L. Messori,et al.  Reactions of gold(III) complexes with serum albumin. , 2003, European journal of biochemistry.

[28]  Hongzhe Sun,et al.  Gold(III) porphyrins as a new class of anticancer drugs: cytotoxicity, DNA binding and induction of apoptosis in human cervix epitheloid cancer cells. , 2003, Chemical communications.

[29]  S. Berners‐Price,et al.  Mechanisms of cytotoxicity and antitumor activity of gold(I) phosphine complexes: the possible role of mitochondria , 2002 .

[30]  E. Tiekink.  Gold derivatives for the treatment of cancer. , 2002, Critical reviews in oncology/hematology.

[31]  L. Messori,et al.  Gold(III) complexes with bipyridyl ligands: solution chemistry, cytotoxicity, and DNA binding properties. , 2002, Journal of medicinal chemistry.

[32]  Zou,et al.  First Crystal Structure of a Medicinally Relevant Gold Protein Complex: Unexpected Binding of , 2000, Angewandte Chemie.

[33]  C. Shaw,et al.  Kinetics and Mechanism of the Reaction between Serum Albumin and Auranofin (and Its Isopropyl Analogue) in Vitro. , 1996, Inorganic chemistry.

[34]  P. Sadler,et al.  A new structural transition of serum albumin dependent on the state of Cys34. Detection by 1H-NMR spectroscopy. , 1994, European journal of biochemistry.

[35]  D A Scudiero,et al.  Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm. , 1989, Journal of the National Cancer Institute.

[36]  S. Crooke,et al.  Interactions of gold coordination complexes with DNA. , 1986, Biochemical pharmacology.

[37]  Vladimir N Uversky,et al.  Insights in the (un)structural organization of Bacillus pasteurii UreG, an intrinsically disordered GTPase enzyme. , 2012, Molecular bioSystems.

[38]  M. Manassero,et al.  µ-Oxo and alkoxo complexes of gold(III) with 6-alkyl-2,2′-bipyridines. Synthesis, characterization and X-ray structures , 1998 .